🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT06699134
Recruiting Observational

Hi-Fatigue G Bone Cement Retrospective Study

NCT06699134 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2024-11-19
Last updated
2025-12-02

Condition(s) studied

Total Hip and Knee Arthroplasties

Investigational drug(s) / intervention(s)

Total knee arthroplastyTotal Hip arthroplasty

Total knee arthroplasty: Primary total knee replacement using Hi-Fatigue G Bone Cement and a Zimmer Biomet implant

Total Hip arthroplasty: Primary total hip replacement using Hi-Fatigue G Bone Cement and a Zimmer Biomet implant

Study summary

The objective of this retrospective monocentric study is to collect survivorship and clinical data confirming safety, performance and clinical benefits for the Hi-Fatigue G Bone Cement.

The assessments will include:

* Radiological analysis performed at different time points according to the standard of care of the hospital
* Implant survivorship and safety based on removal of a study device
* Patient reported outcome measures (PROMs)

Primary endpoint:

Assessment of radiolucent lines around the components (tibial, femoral, acetabular) at 5 years (in accordance with the hospital standard of care).

Secondary endpoints:

* Evaluation of implant survivorship and safety by monitoring the frequency and incidence of adverse events. Relation of the events to implant, instrumentation and/or procedure should be specified.
* Evaluation of PROMs
* Obtain information regarding the cementing technique and handling of the cement, if available

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Subject qualified for cemented TKA or THA with a Zimmer Biomet implant * Subject is willing and able to give written informed consent for retrospective data collection and undergo interim and final evaluation (X-Ray \& Scores completion) * Subject \> 18 years old Exclusion Criteria: * Muscle wasting * Neuromuscular compromise in the affected limb * Known hypersensitivity to any of the cement constituents * Subjects with severe renal failure * Bilateral interventions * Subject is a vulnerable subject (prisoner, mentally incompetent or unable to understand what participation to the study entails, known alcohol or drug abuser, anticipated to be non-compliant)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Klinikum Weiden Weiden Bavaria Recruiting

More Zimmer Biomet trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06699134 on ClinicalTrials.gov ↗ ← All trials in Germany